Retirement Planning Company of New England’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.09M Sell
20,235
-106
-0.5% -$22.8K 1.83% 8
2026
Q1
$4.42M Buy
20,341
+300
+1% +$66.5K 1.8% 8
2025
Q4
$4.58M Sell
20,041
-69
-0.3% -$15.7K 1.84% 11
2025
Q3
$4.66M Buy
20,110
+48
+0.2% +$9.78K 1.87% 9
2025
Q2
$3.72M Buy
20,062
+335
+2% +$62.3K 1.66% 10
2025
Q1
$4.13M Sell
19,727
-363
-2% -$70.6K 2.06% 4
2024
Q4
$3.57M Buy
20,090
+707
+4% +$130K 1.73% 10
2024
Q3
$3.83M Buy
19,383
+77
+0.4% +$14.4K 1.91% 7
2024
Q2
$3.31M Buy
19,306
+307
+2% +$50.9K 1.8% 9
2024
Q1
$3.46M Sell
18,999
-7,921
-29% -$1.37M 1.9% 7
2023
Q4
$4.17M Buy
26,920
+511
+2% +$74.5K 1.88% 10
2023
Q3
$3.94M Buy
26,409
+4,633
+21% +$680K 2.19% 5
2023
Q2
$2.93M Buy
21,776
+2,049
+10% +$300K 1.69% 7
2023
Q1
$3.14M Buy
19,727
+55
+0.3% +$8.41K 1.91% 4
2022
Q4
$3.18M Buy
19,672
+387
+2% +$59.3K 2.07% 3
2022
Q3
$2.59M Buy
19,285
+192
+1% +$27.6K 1.87% 4
2022
Q2
$2.92M Sell
19,093
-90
-0.5% -$13.8K 1.99% 3
2022
Q1
$3.11M Sell
19,183
-23
-0.1% -$3.34K 1.76% 6
2021
Q4
$2.6M Buy
+19,206
New +$2.27M 1.27% 12

Other funds holding ABBV

Retirement Planning Company of New England's ABBV Position: Q2 2026 in Review

Retirement Planning Company of New England reduced its AbbVie (ABBV) stake by 0.52% in Q2 2026, selling an estimated $22.8K and leaving 20,235 shares worth $5.09M. The position accounts for 1.83% of the portfolio, ranked #8.

Retirement Planning Company of New England first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 3,393 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Retirement Planning Company of New England held 20,235 shares of AbbVie worth $5.09M as of Q2 2026.
  • Retirement Planning Company of New England sold 106 AbbVie shares in Q2 2026, an estimated $22.8K.
  • AbbVie made up 1.83% of Retirement Planning Company of New England's portfolio in Q2 2026, its #8 holding.
  • Retirement Planning Company of New England first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 3,393 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.